StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report report published on Sunday. The firm issued a sell rating on the stock.
Ayala Pharmaceuticals Stock Performance
Shares of ADXS stock opened at $0.03 on Friday. Ayala Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $1.49. The stock has a 50 day simple moving average of $0.04 and a two-hundred day simple moving average of $0.14. The company has a market cap of $1.28 million, a P/E ratio of 0.00 and a beta of 1.81.
Ayala Pharmaceuticals Company Profile
Featured Stories
- Five stocks we like better than Ayala Pharmaceuticals
- Top Stocks Investing in 5G Technology
- Rocket Lab is the Right Stock for the Right Time
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- High Flyers: 3 Natural Gas Stocks for March 2022
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.